Nexeon Medsystems, Inc. (OTCQB: NXNN) is a global medical device company focused on providing innovative neurostimulation products that improve the quality of life of patients suffering from debilitating neurological diseases. Nexeon has developed and commercialized the Synapse™ neurostimulation system, an adaptive, closed-loop platform that can be utilized to treat a variety of neurological diseases. Our lead program utilizes the Synapse™ system for deep brain stimulation for the treatment of the symptoms associated with Parkinson’s disease.